Alicorp - Public Comps and Valuation Multiples

Alicorp Overview

About Alicorp

Alicorp SA is a Peruvian company that manufactures, imports, exports and distributes mass consumption products across South America. Products are offered through four operating segments: mass Consumption, which contributes to the majority of firm revenue, B2B and aquaculture. Mass consumption products include various oils, hair care products, noodles, drinks, and food products. The B2B segment is the next contributor to revenue and manufactures and supplies products for industrial use such as laundry detergents, soap and stain removers, as well as beauty products. Aquaculture involves the provision of nutritional animal food and the Grinding segment. The company earns the majority of revenue domestically, with the rest coming from other South American countries.

Founded

1956

HQ

Employees

7.6K+

Website

alicorp.com.pe

Sectors

Health & Beauty
Home Care
Food & Beverages

Financials

LTM Revenue $3.1B

LTM EBITDA $447M

EV

$2.3B

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Alicorp Financials

Alicorp has a last 12-month revenue of $3.1B and a last 12-month EBITDA of $447M.

In the most recent fiscal year, Alicorp achieved revenue of $2.8B and an EBITDA of $293M.

Alicorp expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Alicorp valuation multiples based on analyst estimates

Alicorp P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$3.7B	$2.8B	XXX	XXX	XXX
Gross Profit	$743M	$650M	XXX	XXX	XXX
Gross Margin	20%	23%	XXX	XXX	XXX
EBITDA	$240M	$293M	XXX	XXX	XXX
EBITDA Margin	7%	10%	XXX	XXX	XXX
Net Profit	$141M	$50.6M	XXX	XXX	XXX
Net Margin	4%	2%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Alicorp Stock Performance

As of April 15, 2025, Alicorp's stock price is PEN 8 (or $2).

Alicorp has current market cap of PEN 5.3B (or $1.4B), and EV of PEN 8.4B (or $2.3B).

See Alicorp trading valuation data

Alicorp Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$2.3B	$1.4B	XXX	XXX	XXX	XXX	$0.21

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Alicorp Valuation Multiples

As of April 15, 2025, Alicorp has market cap of $1.4B and EV of $2.3B.

Alicorp's trades at 0.7x LTM EV/Revenue multiple, and 5.1x LTM EBITDA.

Analysts estimate Alicorp's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for Alicorp and 10K+ public comps

Alicorp Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$2.3B	XXX	XXX	XXX
EV/Revenue	0.8x	XXX	XXX	XXX
EV/EBITDA	7.7x	XXX	XXX	XXX
P/E	15.0x	XXX	XXX	XXX
P/E/Growth	0.4x	XXX	XXX	XXX
EV/FCF	4.3x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Alicorp Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Alicorp Valuation Multiples

Alicorp's NTM/LTM revenue growth is 17%

Alicorp's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Alicorp's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate Alicorp's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for Alicorp and other 10K+ public comps

Alicorp Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	-22%	XXX	XXX	XXX	XXX
EBITDA Margin	10%	XXX	XXX	XXX	XXX
EBITDA Growth	22%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	27%	XXX	XXX	XXX	XXX
Revenue per Employee	$0.4M	XXX	XXX	XXX	XXX
Opex per Employee	$0.1M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	8%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	8%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	16%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry